Collaboration Agreements (Tables)

12 Months Ended

Dec. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule Of Collaboration Revenue

Revenue was as follows for the years ended December 31, 2023, 2022 and 2021:

	Year Ended December 31,
	2023		2022		2021
Neurocrine Biosciences:
Recognition of the transaction price	$	—	$	372	$	3,715
Research and development services		—		1,938		6,452
Milestone payments		—		7,124		5,270
Pacira BioSciences:
Milestone payments		—		—		3,000
Total revenue	$	—	$	9,434	$	18,437